📅 PUBMED DAILY TRIAGE — 2026-04-04 Window: 2026-04-03T09:00Z → 2026-04-04T09:00Z (CRDT) Topics scanned: 9 | Articles reviewed: ~90 | Candidates evaluated: 22 High priority: 2 | Standard: 14 | Low/archive: 6 | Unsolicited finds: 1 Run status: SUCCESS
🔴🟠 HIGH PRIORITY (8+) — Best Finds by Topic
Hematologic Malignancies
41933136 · Trisomy 8 alters chromatin conformations and activates Y chromosome genes in stem cells to drive a pre-leukemic state · 8/10 · First mechanistic demonstration linking trisomy 8 to MDS/AML through Uty/Kdm6c epigenetic activation in Oncogene
Novel Therapeutics: Immunotherapy, CAR-T, Targeted Therapy
41933267 · Recent advances in CAR T and CAR NK cell therapy for AML · 8/10 · Introduces novel HLA-DRB1 mismatch-targeting strategy for post-transplant AML relapse from Osaka University
Topics with no 8+ articles today:
- CBC-based diagnostics and ML in hematology: best candidate scored 5/10
- Early cancer detection: best candidate scored 6/10
- AI/ML in clinical diagnostics: best candidate scored 6/10
- Precision oncology: best candidate scored 7/10
- Cardiovascular-metabolic: best candidate scored 7/10
- Aging, longevity: best candidate scored 7/10 (preprint cap)
- Rare diseases: best candidate scored 7/10 (preprint cap)
🟢⚪ STANDARD (5-7) — Top by Topic
Hematologic Malignancies
41929632 · BCL-2 inhibitor resistance in TP53-mutated AML · 7/10 · Treatment Innovation 41933230 · Mutational landscape changes of AML relapse post-alloHCT · 7/10 · Genomics/Precision Medicine 41930806 · Transcriptomic-guided NK cell donor selection for AML · 6/10 · Treatment Innovation
Early Cancer Detection
41928241 · AI-powered liquid biopsy in cancer (review) · 6/10 · Early Detection 41928839 · OCT diagnostic accuracy for early oral cancer · 5/10 · Early Detection
AI/ML in Clinical Diagnostics
41930301 · AI-driven digital pathology for cancer diagnostics · 6/10 · Diagnostics
Precision Oncology
41930857 · Biomarker discovery for personalized ICI therapy (EJC) · 7/10 · Genomics/Precision Medicine 41932368 · Radiolabeled cyclic peptides in precision oncology · 5/10 · Treatment Innovation
Novel Therapeutics
41930781 · GLP-1 receptor agonists + immune checkpoint inhibitors · 7/10 · Treatment Innovation 41928252 · In vivo CAR-T therapy: molecular design to delivery · 6/10 · Treatment Innovation 41932429 · NMT inhibitors as cancer drug targets · 5/10 · Drug Development
Cardiovascular-Metabolic
41930072 · Dual GLP-1/GIP receptor agonists in CV prevention · 5/10 · Treatment Innovation
Aging, Longevity, Population Health
41929337 · Deep-learning senescence biomarker (SASP Score) [PREPRINT] · 7/10 · Diagnostics 41933196 · Space as model of accelerated aging (Nature Aging) · 6/10 · Public Health
Rare Diseases
41929321 · Rare variants map 1,342 diseases in 490K genomes [PREPRINT] · 7/10 · Genomics/Precision Medicine
💡 UNSOLICITED FINDS
41931985 · Role of retinal biomarkers in diabetes detection and risk prediction · 5/10 · Early Detection
📊 TODAY'S BREAKDOWN
- By research category: Treatment Innovation (7) | Genomics/Precision Medicine (4) | Diagnostics (4) | Drug Development (3) | Early Detection (3) | Public Health (1)
- By evidence maturity: Exploratory (19) | Validated (2) | Potentially Practice-Changing (0)
- By watchlist topic (reviewed/kept/highest):
- Hematologic malignancies: 10/7/8
- CBC diagnostics/ML: 10/2/5
- Early cancer detection: 10/2/6
- AI/ML diagnostics: 10/3/6
- Precision oncology: 10/2/7
- Novel therapeutics: 10/5/8
- Cardiovascular-metabolic: 10/2/7
- Aging/longevity: 10/3/7
- Rare diseases: 10/1/7
- By source type: peer_reviewed 20 | preprint 2
🔧 RUN NOTES
- Normal 24h window on CRDT, no expansion needed
- Two preprints (PMID 41929337, 41929321) would have scored 8+ if peer-reviewed; score capped at 7 per rubric
- Both HIGH priority articles are from hematologic malignancy/immunotherapy domains, continuing recent trend
- GLP-1 + ICI cross-domain review (PMID 41930781, score 7) is conceptually novel — worth watching for prospective trial data
- Deep learning SASP Score (PMID 41929337) with UK Biobank development and independent RCT validation is a strong preprint candidate for follow-up